Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

May 20, 2022

SELL
$1.84 - $6.44 $59,422 - $207,979
-32,295 Closed
0 $0
Q4 2019

May 12, 2022

BUY
$3.06 - $8.78 $98,822 - $283,550
32,295 New
32,295 $187,000

Others Institutions Holding AQST

About Aquestive Therapeutics, Inc.


  • Ticker AQST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,350,700
  • Market Cap $141M
  • Description
  • Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...
More about AQST
Track This Portfolio

Track True North Advisors, LLC Portfolio

Follow True North Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True North Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True North Advisors, LLC with notifications on news.